| Followers | 245 |
| Posts | 13889 |
| Boards Moderated | 0 |
| Alias Born | 05/19/2015 |
Wednesday, December 22, 2021 10:07:13 AM
Yes RGBP is Stock-to-buy IMO! Also!
Thanks for the inspiration!
Now let me show RGBP doubters how to make bank$$$$$$$$$$$$
Kept it simple!
Buy Low Sell High
RGBP has already ran over 8 cents twice this year. Looks like it’s about that time again.
3rd time the charm!
RGBP in it to Win it Again!
Buy Low Sell High
RGBP
Buy 999,999 Shares Limit $0.0141 Expires on 02/22/2022 3:42 PM 12/21/2021
Bought 806,123 $0.0141 Settles 12/23/2021 3:42 PM 12/21/2021
Bought 193,876 $0.0141 Settles 12/27/2021 9:47 AM 12/22/2021
CLOSED Filled
RGBP
Buy 500,000 Shares Limit $0.0141 Expires on 02/22/2022 10:04 AM 12/22/2021
Bought 66,186 $0.0141 Settles 12/27/2021 10:04 AM 12/22/2021
OPEN Partial Fill
Thanks for the inspiration!
Now let me show RGBP doubters how to make bank$$$$$$$$$$$$
Kept it simple!
Buy Low Sell High
RGBP has already ran over 8 cents twice this year. Looks like it’s about that time again.
3rd time the charm!
RGBP in it to Win it Again!
Buy Low Sell High
RGBP
Buy 999,999 Shares Limit $0.0141 Expires on 02/22/2022 3:42 PM 12/21/2021
Bought 806,123 $0.0141 Settles 12/23/2021 3:42 PM 12/21/2021
Bought 193,876 $0.0141 Settles 12/27/2021 9:47 AM 12/22/2021
CLOSED Filled
RGBP
Buy 500,000 Shares Limit $0.0141 Expires on 02/22/2022 10:04 AM 12/22/2021
Bought 66,186 $0.0141 Settles 12/27/2021 10:04 AM 12/22/2021
OPEN Partial Fill
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
